Placebo News and Research

RSS

Anti-hypertensive drug clonidine before non-cardiac surgery reduces risk of complications due to inadequate blood flow to the heart

Patients with or at risk for heart disease who take the anti-hypertensive drug clonidine before non-cardiac surgery can significantly reduce the risk of complications and death due to inadequate blood flow to the heart, according to a study by UCSF researchers at the San Francisco Veterans Affairs Medical Center.

29 Jul 2004

Study shows frovatriptan effective in preventing menstrual associated migraine

A study conducted by researchers at Thomas Jefferson University, Philadelphia, and published Tuesday, July 27, 2004, in the journal Neurology, shows that Frova (frovatriptan), a triptan class migraine therapy with a long half life, significantly reduced the incidence of menstrual associated migraines (MAM) in women who took the medication preventively, in advance of anticipated onset of headache.

29 Jul 2004

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

An international study with nearly 900 patients co-infected with Human Immunodeficiency Virus (HIV) and hepatitis C virus (HCV) has shown that HCV can be treated effectively and safely, without compromising the patient’s HIV therapy.

29 Jul 2004

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.

28 Jul 2004

Definite link between migraine and menstruation

Two new studies shows a definite link between migraine and menstruation. Approximately half of all women who seek clinical treatment for migraines have reported an association between migraine and menstruation, and a recent study by the City of London Migraine Clinic confirms their experience.

26 Jul 2004

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Y's Therapeutics, a privately held biopharmaceutical company, said today it has submitted applications to the Ethics Committee and Ministry of Health (BfArM) in Germany to begin Phase II clinical trials for its two most advanced projects, YSIL6 for rheumatoid arthritis and YSTH2 for asthma.

26 Jul 2004

Donepezil may have short-term benefit for mild cognitive impairment

People with mild cognitive impairment (MCI) taking the drug donepezil were at reduced risk of progressing to Alzheimer's disease (AD) for the first 18 months of a 3-year study when compared with their counterparts on placebo

26 Jul 2004

Correlation between caffeine intake at mealtime and increased glucose and insulin levels among diabetics

Duke University Medical Center researchers at have found a strong correlation between caffeine intake at mealtime and increased glucose and insulin levels among people with type-2 diabetes.

26 Jul 2004

Drug used to treat schizophrenia and other psychotic disorders appears effective at treating Alzheimer’s disease

Doctors are reporting some success in treating one of the most troubling symptoms of dementias such as Alzheimer’s disease. A drug commonly used to treat schizophrenia and other psychotic disorders appears effective at reducing actions like screaming at or slapping caregivers – agitated behaviors that occur in as many as half of patients.

23 Jul 2004

First well-conducted studies of use of antipsychotics in people with Alzheimer’s

A member of a class of drugs that are widely prescribed for abnormal behavioral symptoms in Alzheimer’s – but not often studied in people with the degenerative brain disease – proved to be effective and well tolerated in treating agitation in people with severe Alzheimer’s

23 Jul 2004

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Elan Corporation and Wyeth Pharmaceuticals have announced several key findings from their Phase IIa clinical trial of an investigational Alzheimer's disease (AD) treatment, AN-1792, which were presented in Philadelphia at the 9th International Conference on Alzheimer's Disease and Related Disorders.

22 Jul 2004

Donepezil may have short-term benefit for mild cognitive impairment

21 Jul 2004

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

Botox approved as treatment for severe underarm sweating

The FDA has approved Botulinum Toxin Type A (Botox) to treat severe underarm sweating known as “primary axillary hyperhidrosis” that cannot be managed by topical agents such as prescription antiperspirants. Botox has already been approved for several other purposes.

20 Jul 2004

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

An article in the July issue of the Archives of Neurology reports that the drugs levodopa and pramipexole both appear to be reasonable options as initial therapy for Parkinson disease, but they are associated with different efficacy and adverse effects.

20 Jul 2004

Placebo News and Research

Anti-hypertensive drug clonidine before non-cardiac surgery reduces risk of complications due to inadequate blood flow to the heart

Study shows frovatriptan effective in preventing menstrual associated migraine

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

Definite link between migraine and menstruation

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Donepezil may have short-term benefit for mild cognitive impairment

Correlation between caffeine intake at mealtime and increased glucose and insulin levels among diabetics

Drug used to treat schizophrenia and other psychotic disorders appears effective at treating Alzheimer’s disease

First well-conducted studies of use of antipsychotics in people with Alzheimer’s

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Donepezil may have short-term benefit for mild cognitive impairment

A new vaccine that may delay cancer recurrence

Botox approved as treatment for severe underarm sweating

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

ARICEPT® delays the onset of Alzheimer's among people with mild cognitive impairment

Drug slows the progression of mild cognitive impairment

Results from clinical trial of TA-NIC, therapeutic vaccine for the treatment of nicotine addiction

Cannabis extract helps reduce pain in multiple sclerosis patients

3M granted FDA approval for cream to treat superficial basal cell carcinoma

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News